PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
All content for PeerVoice Clinical Pharmacology Video is the property of PeerVoice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Alberto Ortiz, MD, PhD - Rare, Complex, and Life-Threatening: Recognizing and Responding to Atypical Hemolytic Uremic Syndrome
PeerVoice Clinical Pharmacology Video
25 minutes 32 seconds
3 months ago
Alberto Ortiz, MD, PhD - Rare, Complex, and Life-Threatening: Recognizing and Responding to Atypical Hemolytic Uremic Syndrome
Visit https://www.peervoice.com/CAX860 to view the entire programme with slides. After completing “Alberto Ortiz, MD, PhD - Rare, Complex, and Life-Threatening: Recognizing and Responding to Atypical Hemolytic Uremic Syndrome”, participants will be able to: Describe the pathophysiology of atypical hemolytic uremic syndrome (aHUS), including the involvement of terminal complement dysregulation and how this impacts renal function; Assess the clinical significance of clinical trial data and real-world evidence evaluating the use of complement component C5 inhibitors in managing aHUS; Implement evidence-based best practices for the timely recognition and diagnosis of aHUS in patients who present with symptoms of this condition; and Formulate appropriate, individualized approaches to managing aHUS in patients presenting for first-line treatment or experiencing relapse after treatment discontinuation.
PeerVoice Clinical Pharmacology Video
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
